Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Danesi

Showing results (41-50 of 160) with videos related to

Pageof 16
Sort By:
International Journal of Cancer|September 27, 1995
Increased susceptibility of ras-transformed cells to phenylacetate is associated with inhibition of p21ras isoprenylation and phenotypic reversionS Shack, L C Chen, A C Miller, et al.
In Vivo (Athens, Greece)|November 1, 1992
Morphohistochemical characterization of suramin--induced chronic toxicity in rat kidneyP Soldani, R Danesi, M P Ricciardi, et al.
Mutation Research|July 24, 2001
Three novel mutations causing a truncated protein within the RP2 gene in Italian families with X-linked retinitis pigmentosaA De Luca, I Torrente, M Mangino, et al.
Anticancer Research|July 1, 1988
Doxorubicin affects both the number and the morphology of specific atrial granules in dog heartO Bellini, R Danesi, N Bernardini, et al.
Journal of Neurochemistry|May 29, 1998
Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cellsD C Crick, D A Andres, R Danesi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
3'-Deamino-3'-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): a new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicityR Danesi, C Agen, M Grandi, et al.
Trends in Pharmacological Sciences|August 2, 2001
Pharmacogenetic determinants of anti-cancer drug activity and toxicityR Danesi, F De Braud, S Fogli, et al.
Anticancer Research|September 1, 1986
Superoxide anion production by adriamycinol from cardiac sarcosomes and by mitochondrial NADH dehydrogenaseP G Gervasi, M R Agrillo, L Citti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
In vitro studies on gemcitabine combinations with other antiblasticsE Giovannetti, R Danesi, V Mey, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529C Agen, N Bernardini, R Danesi, et al.
Pageof 16

Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|September 27, 1995
Increased susceptibility of ras-transformed cells to phenylacetate is associated with inhibition of p21ras isoprenylation and phenotypic reversionS Shack, L C Chen, A C Miller, et al.
In Vivo (Athens, Greece)|November 1, 1992
Morphohistochemical characterization of suramin--induced chronic toxicity in rat kidneyP Soldani, R Danesi, M P Ricciardi, et al.
Mutation Research|July 24, 2001
Three novel mutations causing a truncated protein within the RP2 gene in Italian families with X-linked retinitis pigmentosaA De Luca, I Torrente, M Mangino, et al.
Anticancer Research|July 1, 1988
Doxorubicin affects both the number and the morphology of specific atrial granules in dog heartO Bellini, R Danesi, N Bernardini, et al.
Journal of Neurochemistry|May 29, 1998
Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cellsD C Crick, D A Andres, R Danesi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
3'-Deamino-3'-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): a new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicityR Danesi, C Agen, M Grandi, et al.
Trends in Pharmacological Sciences|August 2, 2001
Pharmacogenetic determinants of anti-cancer drug activity and toxicityR Danesi, F De Braud, S Fogli, et al.
Anticancer Research|September 1, 1986
Superoxide anion production by adriamycinol from cardiac sarcosomes and by mitochondrial NADH dehydrogenaseP G Gervasi, M R Agrillo, L Citti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
In vitro studies on gemcitabine combinations with other antiblasticsE Giovannetti, R Danesi, V Mey, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529C Agen, N Bernardini, R Danesi, et al.
Pageof 16